Today in News History

On July 12, several notable moments in the history of News stand out. In 1789, In response to the dismissal of the French finance minister Jacques Necker, the radical journalist Camille Desmoulins gives a speech which results in the storming of the Bastille two days later. In 1854, George Eastman, American businessman, founded Eastman Kodak (died 1933) was born. In 1933, Victor Poor, American engineer, developed the Datapoint 2200 (died 2012) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1947, Richard C. McCarty, American psychologist and academic was born. In 1959, Karl J. Friston, English psychiatrist and neuroscientist was born. In 2001, Space Shuttle program: Space Shuttle Atlantis is launched on mission STS-104, carrying the Quest Joint Airlock to the International Space Station. In 2006, The 2006 Lebanon War begins. In 2014, Valeriya Novodvorskaya, Russian journalist and politician (born 1950) passed away. In 2024, Ruth Westheimer, German-American sex therapist (born 1928) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

Silence Therapeutics: PV Data Could Wake The Stock (Initiating Buy)

Seeking Alpha

Seeking Alpha

·

July 12, 2026

·

lean right
Narrative Intelligence Brief

This article was published by Seeking Alpha, a source frequently categorized with a lean right bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Seeking Alpha, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 5 related reports from 5 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

5 sources

Left 40%

Center 20%

Right 40%


Seeking Alpha

lean right

· Jun 30, 2026

Plus Therapeutics, Inc. (PSTV) Discusses Rebranding and Integrated CNS Oncology Platform Strategy Transcript

Plus Therapeutics, Inc. (PSTV) Discusses Rebranding and Integrated CNS Oncology Platform Strategy Transcript

The Motley Fool

lean left

· Jun 29, 2026

Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?

This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.

Bloomberg

lean left

· Jul 12, 2026

The $360 Billion Market that Medicine Got Wrong for 20 Years

The 360 billion dollar women’s health market is made of several categories that are often overlooked – one of which is menopause. The condition has gone largely unnoticed by pharma and biotech firms, employers, and investors, despite affecting half the world’s population and contributing to major losses in productivity. That is starting to change as celebrities like Naomi Watts, startups such as Stripes and Midi Health, and investors including Amboy Street Ventures turn women’s midlife health into a fast-growing market. The shift has accelerated alongside the FDA’s rollback of long-standing warnings on hormone replacement therapy. But as the category grows, so does the challenge for women trying to distinguish evidence-based care from unproven wellness products and marketing hype. (Source: Bloomberg)

Investing.com

center

· Jun 22, 2026

Citizens reiterates Prime Medicine stock rating on gene therapy focus

Citizens reiterates Prime Medicine stock rating on gene therapy focus

The Hindu BusinessLine

lean right

· Jul 6, 2026

Revise the National list of essential medicines: civil society organisation

They called for a “transparent, time-bound, and conflict of interest-free process to revise the NLEM, ensuring that it reflects the latest evidence, public health priorities, and the WHO Model List of Essential Medicines”

Topics:

Business · 4
Politics · 1

Related coverage for "Silence Therapeutics: PV Data Could Wake The Stock (Initiating Buy)": Seeking Alpha — Plus Therapeutics, Inc. (PSTV) Discusses Rebranding and Integrated CNS Oncology Platform Strategy Transcript. The Motley Fool — Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?. Bloomberg — The $360 Billion Market that Medicine Got Wrong for 20 Years. Investing.com — Citizens reiterates Prime Medicine stock rating on gene therapy focus. The Hindu BusinessLine — Revise the National list of essential medicines: civil society organisation